Nuclear Medicine and Biology
Volume 34, Issue 4 , Pages 345-351, May 2007

One-step high-radiochemical-yield synthesis of [18F]FP-CIT using a protic solvent system

  • Sang Ju Lee

      Affiliations

    • Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea
    • Department of Chemistry, Inha University, Inchon 402-751, South Korea
  • ,
  • Seung Jun Oh

      Affiliations

    • Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 2 3010 4595; fax: +82 2 3010 4588.
  • ,
  • Dae Yoon Chi

      Affiliations

    • Department of Chemistry, Inha University, Inchon 402-751, South Korea
  • ,
  • Se Hun Kang

      Affiliations

    • Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea
  • ,
  • Hee Seup Kil

      Affiliations

    • Department of Chemistry, Inha University, Inchon 402-751, South Korea
  • ,
  • Jae Seung Kim

      Affiliations

    • Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea
  • ,
  • Dae Hyuk Moon

      Affiliations

    • Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea

Received 8 November 2006; received in revised form 22 January 2007; accepted 16 February 2007.

Abstract 

Although [18F] fluoropropylcarbomethoxyiodophenylnortropane (FP-CIT) is a promising radiopharmaceutical for dopamine transporter imaging, it has not been used for clinical studies because of low radiochemical yield. The purpose of our study was to develop a new radiochemistry method using a protic solvent system to obtain a high radiochemical yield of [18F]FP-CIT in single-step manual and automatic preparation procedures. [18F]F was trapped on a QMA Sep-Pak cartridge or PS-HCO3 cartridge and eluted with Cs2CO3/K222 buffer or TBAHCO3, respectively, or 8 μl of TBAOH was added directly to [18F]F/H218O solution in a reactor without using a cartridge. After drying, [18F] fluorination was performed with 2–6 mg of mesylate precursor, 100 μl of CH3CN and 500 μl of t-BuOH at 50–120°C for 5–30 min, followed by high-performance liquid chromatography (HPLC) purification to obtain the final product. For comparison, the same procedure was performed with a tosylate precursor. Manual synthesis gave a decay-corrected radiochemical yield of 52.2±4.5%, and optimal synthesis conditions were as follows: TBAOH addition, 4 mg of precursor, 100°C and 20 min of [18F] fluorination (n=3). We obtained low radiochemical yields of [18F]FP-CIT with carbonate elution systems such as Cs2CO3 or TBAHCO3. We also developed an automatic synthesis method based on manual synthesis results. In automatic production, we obtained a decay-corrected radiochemical yield of 35.8±5.2% after HPLC purification, and we did not have any synthesis failures (n=14). Here, we describe our new method for the synthesis of [18F]FP-CIT using a protic solvent system. This method gave a high radiochemical yield with high reproducibility and might enable [18F]FP-CIT to be used clinically and commercially.

Keywords: [18F]FP-CIT, Protic solvent, Nucleophilic substitution, Parkinson's disease, Dopamine transporter

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0969-8051(07)00044-3

doi:10.1016/j.nucmedbio.2007.02.007

Nuclear Medicine and Biology
Volume 34, Issue 4 , Pages 345-351, May 2007